Kenvue Inc.
KVUE · NYSE
Analyst Consensus
Analyst Ratings Synthesis
Consensus is Hold across 14 analysts, with a mean price target of $19.50. The supplied data do not report low or high targets, so target clustering and the breadth of the spread cannot be measured. No named analyst is identified as most or least bullish, and no rating or target revisions during the past week are supplied. The substantive disagreement behind the target distribution is therefore not documented. The available research framing is cautiously constructive on near-term fundamentals: Zacks expects Q2 revenue and earnings growth as brand strength, innovation and productivity offset seasonal and cost pressures. That forecast contrasts with the neutral aggregate rating, but the evidence does not attribute differing views to specific analysts or firms.
